POMDOCTOR Proposes ADR Termination, Direct Nasdaq Listing, and 10-to-1 Share Consolidation
POM sits 66% above its 52-week low of $0.5 on light trading volume (0.1× avg).
Summary
POMDOCTOR shareholders will vote September 30 on terminating the ADR program, directly listing ordinary shares on Nasdaq, and a 10-to-1 share consolidation.
Key Events · Corporate Governance and Compliance · POM
-
ADR Termination and Direct Listing Proposed
Shareholders will vote on terminating the ADR program and directly listing Class A ordinary shares on Nasdaq, with both actions occurring on the same date.
-
10-to-1 Share Consolidation
Every 10 Class A and Class B ordinary shares would consolidate into 1 share, reducing authorized capital from 500M to 50M shares to support the post-ADR share price.
-
Conversion Mechanics
Based on the current 1 ADS = 3 ordinary shares ratio, every 10 ADSs would convert to 3 post-consolidation ordinary shares, with fractional shares rounded up.
-
Meeting and Record Date
Extraordinary general meeting set for September 30, 2026; record date September 2, 2026, with 27,802,964 ordinary shares outstanding.
Analysis · POM · Trade & Services
POMDOCTOR is asking shareholders to approve terminating its American Depositary Receipt program and directly listing Class A ordinary shares on Nasdaq, paired with a 10-to-1 share consolidation. The consolidation would reduce authorized shares from 500 million to 50 million and is designed to maintain or increase the per-share price after the ADR-to-ordinary-share conversion. This is a structural change to how investors hold and trade the stock — every 10 ADSs would convert to 3 post-consolidation ordinary shares. The vote is set for September 30, 2026, with a record date of September 2, 2026.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 30% of the 1972 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, POM was trading at $0.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.50 to $115.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.